Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Inventory-to-Revenue : 0.00 (As of Sep. 2022)

---

Arbor Rapha Capital Bioholdings I Inventory-to-Revenue Chart

---

Competitive Comparison of Arbor Rapha Capital Bioholdings I's Inventory-to-Revenue

For the Shell Companies subindustry, Arbor Rapha Capital Bioholdings I's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

---

Arbor Rapha Capital Bioholdings I's Inventory-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Arbor Rapha Capital Bioholdings I's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Arbor Rapha Capital Bioholdings I's Inventory-to-Revenue falls into.

---

Arbor Rapha Capital Bioholdings I Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Arbor Rapha Capital Bioholdings I's Inventory-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as

Arbor Rapha Capital Bioholdings I's Inventory-to-Revenue for the quarter that ended in Sep. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

---

Arbor Rapha Capital Bioholdings I  (NAS:ARCK) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Arbor Rapha Capital Bioholdings I's Days Inventory for the three months ended in Sep. 2022 is calculated as:

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Arbor Rapha Capital Bioholdings I's Inventory Turnover for the quarter that ended in Sep. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

---

Arbor Rapha Capital Bioholdings I Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Arbor Rapha Capital Bioholdings I's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Total Inventories Revenue Days Inventory Cost of Goods Sold Inventory Turnover

---

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Business Description

Executives

Ralph Mack	director	333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Kevin M. Slawin	director, officer: Chief Strategy Officer	C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON TX 77030
Ivan Kaufman	director, 10 percent owner, officer: Chief Executive Officer
Arbor Commercial Mortgage Llc	director, 10 percent owner, officer: Chief Executive Officer	333 EARLE OVINGTON BLVD, STE 900, UNIONDALE NY 11553
Paul Elenio	officer: Chief Financial Officer	C/O ARBOR REALTY TRUST, 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
John Natalone	officer: Treasurer	C/O ARBOR REALTY TRUST, INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
William P Connolly	officer: Secretary & Vice President	C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Cyrus D. Walker	director	C/O MARIPOSA CAPITAL, LLC, 500 SOUTH POINTE DRIVE, SUITE 240, MIAMI BEACH FL 33139
Arbor Rapha Capital Llc	director, 10 percent owner, officer: Chief Executive Officer	333 EARLE OVINGTON BLVD., SUITE 900, UNIONDALE NY 11553
Avery Modlin	director	C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553